The Drug-Induced Respiratory Disease Website and App

Frequency - Incidence

Incidence of respiratory adverse event(s) due to the specific drug as assessed by number of reported/published cases in the literature. Red digits in stars indicate: 0 = Very rare, questionable signal · 1 = < 10 cases · 2 = 10-50 cases · 3 = 50–100 cases · 4 = 100-200 cases · 5 = >200 cases

Evidence level/grade

Evidence level for respiratory adverse event(s) due to the specific drug as estimated using Hill’s (1965), Naranjo’s (1981), and Bégaud’s (1985) criteria applied to published cases. Blue digits in stars indicate: 0 = Questionable · 1 = Low · 2 = Moderate · 3 = Robust · 4 = Definite · 5 = Unquestionable, pathognomonic

I.c

Eosinophilic pneumonia (pulmonary infiltrates and eosinophilia)

Publications

Barrio Piqueras M, Ezponda A, Felgueroso C, Urtasun C, Di Frisco IM, Larrache JC, Bastarrika G, Alcaide AB

Acute Eosinophilic Pneumonia Following mRNA COVID-19 Vaccination: A Case Report.

Archivos de bronconeumologia 2021 Nov 16;; — 2021 Nov 16

May J, Draper A, Aul R

Eosinophilic pneumonia and COVID-19 vaccination.

QJM : monthly journal of the Association of Physicians 2022 Feb 15;; — 2022 Feb 15

Miqdadi A, Herrag M

Acute Eosinophilic Pneumonia Associated With the Anti-COVID-19 Vaccine AZD1222.

Cureus 2021 Oct;13;e18959 — 2021 Oct — e18959